Are two doses of human papillomavirus vaccine sufficient for girls aged 15–18 years? Results from a cohort study in India

Extending two-dose recommendations of HPV vaccine to girls between 15 and 18 years will reduce program cost and improve compliance. Immunogenicity and vaccine targeted HPV infection outcomes were compared between 1795 girls aged 15–18 years receiving two (1–180 days) and 1515 girls of same age recei...

Descripción completa

Detalles Bibliográficos
Autores principales: Bhatla, Neerja, Nene, Bhagwan M., Joshi, Smita, Esmy, Pulikottil O., Poli, Usha Rani Reddy, Joshi, Geeta, Verma, Yogesh, Zomawia, Eric, Pimple, Sharmila, Prabhu, Priya R., Basu, Partha, Muwonge, Richard, Hingmire, Sanjay, Sauvaget, Catherine, Lucas, Eric, Pawlita, Michael, Gheit, Tarik, Jayant, Kasturi, Malvi, Sylla G., Siddiqi, Maqsood, Michel, Angelika, Butt, Julia, Sankaran, Subha, Kannan, Thiraviam Pillai Rameshwari Ammal, Varghese, Rintu, Divate, Uma, Willhauck-Fleckenstein, Martina, Waterboer, Tim, Müller, Martin, Sehr, Peter, Kriplani, Alka, Mishra, Gauravi, Jadhav, Radhika, Thorat, Ranjit, Tommasino, Massimo, Pillai, M. Radhakrishna, Sankaranarayanan, Rengaswamy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6047463/
https://www.ncbi.nlm.nih.gov/pubmed/29578097
http://dx.doi.org/10.1016/j.pvr.2018.03.008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6047463/
https://www.ncbi.nlm.nih.gov/pubmed/29578097
http://dx.doi.org/10.1016/j.pvr.2018.03.008

Ejemplares similares